Abstract
OBJECTIVE
To assess the efficacy and safety of ginger-indirect moxibustion for chronic fatigue syndrome (CFS).
METHODS
In this central randomized, controlled trial, 290 CFS participants were recruited and randomly allocated to group A (ginger-indirect moxibustion plus acupuncture) or group B (acupuncture alone). The study consisted of a treatment period of 8 weeks with a total of 24 treatments (3 sessions per week, every other day), and a follow-up period of 12 weeks. The outcome was measured by Fatigue Severity Scale (FSS), Psychological Health Report (SPHERE), the Self-rating depression scale (SDS) and the Hamilton anxiety scale (HAMA) at baseline, 2, 4, 6, 8, 12 and 20 weeks.
RESULTS
With the treatment undergoing, the changes of FSS, SPHERE, SDS and HAMA scores in both groups increased gradually, and the effect maintained at the 12th week. Between groups, significantly higher score changes were seen in group A in FSS after 4 weeks treatment (11.94 vs 9.12, 95%CI: 0.94, 4.7) and in SPHERE after 2 weeks treatment (3.7 vs 2.27, 95%CI: 0.56, 2.31). But for SDS and HAMA, the improvement did not differ significantly between groups. No severe adverse events were reported.
CONCLUSION
Ginger-indirect moxibustion is a safe and effective intervention to relieve fatigue and accompanying physical symptoms of CFS.
Keywords: ginger-indirect moxibustion; fatigue syndrome, chronic; treatment outcome; safety; randomized controlled trial
1. INTRODUCTION
Chronic Fatigue Syndrome (CFS) is the presence of debilitating fatigue which lasts for a minimum of six months and is not relieved by rest, accompanied by nonspecific symptoms,1 such as sleep disturbance and pain. The prevalence of CFS is estimated 40% globally, while most of suffers are young and women.2 CFS affects patients' working and body condition, and hence places burden on society. Due to the unclear pathophysiological mechanisms of CFS,3 no specific pharmacological treatment is recommended and patients may benefit from alternative therapies such as acupuncture,4 yoga,5-7 cognitive behavior therapy or graded exercise therapy. Moxibustion treatment is a method of direct or indirect warm stimulation on acupoints by burning mugwort. According to the theory of Traditional Chinese Medicine (TCM), Yang Qi deficiency is the main reason for fatigue, and moxibustion is widely used for fatigue relief due to its warm effect.8,9 However, systemic reviews based on RCTs didn't draw firm conclusion on the effectiveness of moxibustion in the treatment of CFS, due to the limited and poor quality of researches.
For CFS patients, ginger-indirect moxibustion on Governor Vessel (GV, Dumai) is regarded as one of the best approaches in TCM, with the advantage of strong Yang-warming function. Therefore, we designed a randomized controlled trial to investigate the effect and safety of ginger-indirect moxibustion by comparing ginger-indirect moxibustion plus acupuncture with acupuncture alone. For the clinical operability, moxa box moxibusion over ginger slices was applied from Dazhui (GV14) to Yaoshu (GV2) as well as the same level of 1st bladder meridian on the back to reduce burning and enhance therapeutic effect.
2. METHODS
2.1. Design
This randomized, controlled trial was conducted at the Center of Preventive Medicine of Hospital of Chengdu University of TCM, the Center of Preventive Medicine of Chengdu Integrated TCM and Western Medicine Hospital, the Center of Preventive Medicine and Department of acupuncture of Affiliated TCM Hospital of Southwest Medical University, and the Center of Preventive Medicine of Deyang People's Hospital, between February 2016 and December 2017. This trial followed the rules of the Declaration of Helsinki and the Good Clinical Practice Guidelines, with unique registration number (ChiCTR-INR-16007810) at http://www.chictr.org/cn/. The protocol was approved by the Ethics Committee of Teaching Hospital of Chengdu University of TCM in 2015 (No. 2014KL-018). Written informed consent will be obtained from every patient before participation. Patients were informed that a single acupuncture therapy or a combined therapy of acupuncture and moxibustion would be compared, and no matter which therapy they would receive, there would be positive effective.
The study consisted of a 7-day run-in period prior to randomization, a treatment period of 8 weeks with a total of 24 treatments (3 sessions per week, every other day), and a follow-up period of 12 weeks. After characteristic laboratory abnormalities exclusion in the run-in period, CFS patients were randomly allocated to group of ginger-indirect moxibustion plus acupuncture (treatment group, group A), or acupuncture (control group, group B) in a 1:1 ratio by central randomization.
2.2. Participates
Adult patients aged 18 to 55 meeting the CFS diagnostic criteria were recruited. The criteria was (a) chronic fatigue should be lasting and can't be explained by illness, (b) debilitating fatigue predated and was accompanied by at least 4 of 8 designated symptoms which persisted or recurred during 6 or more consecutive months of illness: post-exertional malaise lasting more than 24 h; unrefreshing sleep; impaired short-term memory or concentration which is severe enough to cause substantial reduction in previous levels of occupational, educational, social, or personal activities; headaches of a new type, pattern, or severity; muscle pain; multi-joint pain without swelling or redness; sore throat; and tender on cervical/axillary lymph nodes.
Exclusion criteria were (a) fatigue associated with the following diseases: organ failure; chronic infections (e.g., acquired immune deficiency syndrome, hepatitis B or C); rheumatic and chronic inflammatory diseases; major neurologic diseases (e.g., multiple sclerosis, neuromuscular diseases, epilepsy or other diseases requiring ongoing medication that could cause fatigue; stroke, head injury with residual neurologic deficits); diseases requiring systemic treatment (e.g., organ or bone marrow transplantation, systemic chemotherapy, radiation of brain, thorax, abdomen, or pelvis); major endocrine diseases (e.g., hypopituitarism, adrenal insufficiency); sleep apnea and narcolepsy, (b) the presence of pregnancy or lactation, (c) the physical contraindications to acupuncture and moxibustion treatment.
Parts of participants were recruited from the Medical Examination Center of responding hospitals. The other ways of participant recruitment were posters displayed in hospitals and communities, advertisements on local newspapers. Before trial entry, a face-to-face medical assessment including history, physical and mental state examinations were held by the clinical trial coordinator to ensure participants meet the criteria of CFS.1 Then laboratory tests recommended by the International Chronic Fatigue Syndrome Study Group were taken to exclude alternative diagnoses.
2.3. Randomization and blinding
Pre-programmed central randomization process was carried out in this trial to obtain the adequate allocation. Only appointed investigators could ask for random number and group assignment through any of the two ways: pre-approved mobile phone text or web, by providing information about eligible patients' name, birthday, and gender. Once the unique random number and group assignment were generated, a feedback, containing a random number, the group assignment code, and the patient's basic information would be automatically sent back through the Center computer system.
The outcome assessors and statistical analysts were blinded to the intervention assignments throughout the trial.
2.4. Intervention
Practitioners: certified acupuncturists who had a TCM license and at least 2-year clinical experiences were trained to participate in this trial. The SOP training included the method of central randomization, criteria of inclusion and exclusion, location of acupoints and the correct manipulation of ginger-indirect moxibustion. In each clinic, one acupuncturist was responsible for diagnosis and giving patient informed consent. Another acupuncturist was in charge of treatment in line with SOP.
Ginger-indirect moxibustion plus acupuncture group (group A): acupuncture: Baihui (GV20), Qihai (CV6), Zusanli (ST36), Taixi (KI3) or Ganshu (BL18), Pishu (BL20), Shenshu (BL23) were selected alternatively based on the meridian and acupoint theories,10,11 and a review of the ancient and modern literature. Sishen-cong (EX-HN1) was added if sleep problem and poor memory were reported. Neiguan (PC6) and Sanyinjiao (SP6) were added if patients suffered extra problems of sleep or digestion. Except for Baihui (GV20), Qihai (CV6) and Sishen-cong (EX-HN1), all the other acupoints were punctured bilaterally by sterile disposable stainless needles (40 or 25 mm in length and 0.25 mm in diameter; Hwato, Suzhou, China, PRC). The depth of puncture was as follow:
Baihui (GV20), Sishen-cong (EX-HN1): horizontal needling to a depth of 0.5 to 0.8 cun;
Ganshu (BL18): oblique needling at a depth of 0.5 to 0.8 cun;
Qihai (CV6), Neiguan (PC6) and Taixi (KI3): perpendicular needling to a depth of 0.5 to 0.8 cun;
Sanyinjiao (SP6), Zusanli (ST36), Pishu (BL20) and Shenshu (BL23): perpendicular needling to a depth of 0.5 to 1 cun.
Twirling and rotating, lifting and thrusting manipulation was applied to promote Qi arrival and then needles were retained for half an hour.
Ginger-indirect moxibustion: Ginger-indirect moxi-bustion on Governor Vessel and Bladder Meridian was applied after needle withdrawal. Patients were asked to expose the whole back completely. Five or six three-hole Moxa boxes (the number of boxes depended on the patients' height; Figure 1A) were placed paralleled from Dazhui (GV14) to Yaoshu (GV2) over ginger slices for 2 mm in thickness. The distance between the center of nearby holes was 4.8 cm to ensure the temperature of moxa stick (pure-mugwort moxa stick; 20 cm in length and 18 mm in diameter; Hwato, Suzhou, China, PRC; Figure 1B) covered the Governor Vessel and the 1st line of Bladder Meridian. During the 45-minute ginger-indirect moxibustion treatment, the depth of moxa sticks was regulated every 5 min to maintain full combustion and obtain equal warm stimulation.
Figure 1. Ginger-indirect moxibustion group.
A: ginger-indirect moxibustion manipulation; B: moxibustion box.
Patients in group a received 24 sessions of acupuncture and moxibustion treatment over a period of 8 weeks (1 session per day, every two sessions with an interval of one day, 3 sessions per week).
Acupuncture group (group B): in group B, patients received the same acupuncture treatment and treatment sessions as in group A.
2.5. Outcome measures
Primary outcomes: the improvement of the Fatigue Severity Scale (FSS) score was measured as the primary outcome. The FSS is a nine-statement questionnaire with a ranging score of 1-7 of each statement. The higher score indicates worse fatigue.12 It was assessed at baseline, weeks 2, 4, 6, 8 (the end of treatment), 12 and 20.
Secondary outcomes: the secondary outcomes included the change of the Somatic and Psychological Health Report (SPHERE), the Self-rating depression scale (SDS), and the Hamilton anxiety scale (HAMA). The 34-item SPHERE assessed a wide range of physical and psychological symptoms identifying the key clinical features of prolonged fatigue states, with higher scores indicating greater fatigue and mental distress.13 The SDS and HAMA are specific scales to assess the symptoms of anxiety/depression, with higher scores indicating greater mental distress. All the secondary outcomes were assessed at baseline, weeks 2, 4, 6, 8, 12 and 20.
Sample size: the sample size was determined based on the primary outcome.14 As reported in the previous literature, there was an improvement of 8.38 on the FSS score after treatment with acupuncture. We anticipated an improvement of no less than 8.88 on the FSS score after acupuncture and moxa treatment in this trial. Given this estimate, with 90% power and a 5% level of significance, at least 145 patients in each group were required to allow for a 10% withdrawal rate.
Statistical methods: the primary statistical analyses were conducted in full analysis set (FAS), which based on the intent-to-treat (ITT) population, consisting of all randomized population who toke at least once treatment and at least one primary outcome evaluation on treatment. For missing data at endpoint (9 cases), a last observation carried forward (LOCF) method was used. The sensitivity analyses based on the per-protocol set (PPS) and complete case set by dropping those with at least once missing of outcome were also conducted as supplementary, respectively.
Quantitative data were shown by mean with standard deviation (SD) or median with percentile (QL-QU), while qualitative variables were expressed by frequency and proportion. The change of outcome assessed during treatment (weeks 2, 4, 6, 8) and follow-up (weeks 12 and 20) comparing with baseline were shown by mean and 95% certificate interval (CI) in the line chart, by setting the absolute value at baseline as starting point. The outcome difference between group A and group B across various times were shown by mean difference (MD) and 95% CI. All the statistical analyses were performed with R software version 3.6.3 (R Development Core Team, Vienna, Austrian), and a P < 0.05 was considered statistically significant.
Quality control: a strict monitoring system was established to assess the performance of the trial. Independent quality monitors supervised the manipulation on the site and the completion of case report forms monthly. After the fill-in of electro-CRF, quality monitors checked and revised the data to maintain accuracy.
3. RESULTS
3.1. Patient characteristics
Approximately 500 patients were screened and 290 were enrolled in the trial. After exclusion of patients who were repeatedly or erroneously randomized (n = 14), the intention-to-treat population comprised all the remaining 276 patients (138 in group A, 138 in group B). The study flow is depicted in Figure 2. The baseline characteristics of the population were similar between two groups (Table 1).
Figure 2. Study flow.
ITT: intent-to-treat; PP: per-protocol.
Table 1.
Characteristics of patients at baseline
| Item | Group A (n=138) | Group B (n=138) | |
|---|---|---|---|
| Age (years) [median (QL-QU)] | 27.5 (24.5-41.4) | 27.3 (24.5-38.2) | |
| 18-29.99 | 78 (56.52) | 82 (59.42) | |
| 30-39.99 | 22 (15.94) | 25 (18.12) | |
| 40-55.49 | 38 (27.54) | 31 (22.46) | |
| Female [n (%)] | 109 (78.99) | 113 (81.88) | |
| BMI (kg/m2) [mean (SD)] | 21.44 (2.55) | 21.20 (2.54) | |
| Duration of disease (month) [Median (QL-QU)] | 18 (10-30) | 18 (12-30) | |
| Expectant degree for effect [n (%)] | Low | 27 (19.57) | 20 (14.49) |
| Moderate | 68 (49.28) | 77 (55.80) | |
| High | 43 (31.16) | 41 (29.71) | |
| FSS at baseline [mean (SD)] | 39.69 (9.17) | 39.45 (9.13) | |
| SPHERE at baseline [mean (SD)] | 17.54 (4.79) | 17.46 (5.21) | |
| SDS at baseline [mean (SD)] | 48.21 (10.39) | 50.17 (10.99) | |
| HAMA at baseline [mean (SD)] | 12.86 (6.36) | 13.67 (8.22) |
Notes: group A: ginger-indirect moxibustion plus acupuncture for 8 weeks; group B: acupuncture alone for 8 weeks. Data were shown by mean and standard deviation (SD) or median with percentile (QL-QU). FSS: Fatigue Severity Scale; SPHERE: Somatic and Psychological Health Report; SDS: Self-rating Depression Scale; HAMA: Hamilton anxiety scale; BMI: body mass index. All the baseline characteristics of the population did not differ significantly between the groups.
3.2. FSS improvement
The FSS scores continually decreased from baseline in both groups after 2-week, 4-week, 6-week and 8-week treatment and during the follow-up period (Figure 3). Between groups, significant differences were observed, and significantly higher score changes were observed in Groups A after 4 weeks treatment (Table 2).
Figure 3. Outcome change during treatment and follow-up.
Data were shown by mean and 95% confidence interval of difference from baseline, by setting the starting point as the absolute value of specific outcome at baseline. A: Fatigue Severity Scale (FSS) score at baseline and changes after 2, 4, 6 and 8 weeks' treatment and during the follow-up period in A and B groups. Group A demonstrated superiority after 4 weeks treatment, and its superiority sustained until week 20; B: Somatic and Psychological Health Report (SPHERE) at baseline and changes after 2, 4, 6 and 8 weeks' treatment and during the follow-up period in A and B groups. Group A demonstrated superiority after 2 weeks treatment, and its superiority sustained until week 20; C: Self-rating Depression Scale (SDS) at baseline and changes after 2, 4, 6 and 8 weeks' treatment and during the follow-up period in A and B groups. There was no statistical difference between A and B groups; D: Hamilton Anxiety (HAMA) scale at baseline and changes after 2, 4, 6 and 8 weeks' treatment and during the follow-up period in A and B groups. There was no statistical difference between A and B groups).
Table 2.
Outcome difference between groups A and B across various times
| Time | FSS | SPHERE | SDS | HAMA | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group A (n =138) |
Group B (n = 138) |
MD (95% CI) |
Group A (n = 138) |
Group B (n = 138) |
MD (95% CI) | Group A (n = 138) |
Group B (n = 138) |
MD (95% CI) |
Group A (n = 138) |
Group B (n = 138) |
MD (95%CI) |
||||||||
| Week 2 | 7.47 (6.88) |
6.06 (6.62) |
1.41 (–0.18, 3.01) |
3.70 (3.90) |
2.27 (3.52) | 1.43 (0.56, 2.31) |
2.99 (7.57) |
2.01 (6.82) |
0.97 (–0.73, 2.67) |
1.96 (3.81) |
1.57 (3.54) |
0.38 (﹣0.48, 1.25) |
|||||||
| Week 4 | 11.94 (8.42) |
9.12 (7.52) |
2.82 (0.94, 4.70) |
6.30 (4.37) |
4.89 (4.48) |
1.41 (0.36, 2.45) |
4.95 (9.13) | 4.69 (7.78) |
0.26 (–1.74, 2.26) |
3.28 (4.11) |
3.29 (4.72) |
–0.01 (–1.06, 1.03) |
|||||||
| Week 6 | 15.44 (9.61) |
11.76 (8.30) |
3.68 (1.56, 5.80) |
8.28 (5.09) |
6.41 (4.91) |
1.87 (0.69, 3.05) |
7.81 (9.77) | 6.74 (8.80) |
1.07 (–1.12, 3.27) |
5.05 (4.61) |
4.72 (5.29) |
0.33 (–0.85, 1.50) |
|||||||
| Week 8 (Treat end) |
20.22 (10.46) |
14.03 (8.99) |
6.20 (3.89, 8.50) |
10.67 (5.36) | 7.89 (5.03) |
2.78 (1.56, 4.01) |
10.90 (9.68) | 8.83 (9.17) | 2.07 (–0.15, 4.30) |
6.76 (5.22) |
5.49 (5.84) |
1.27 (–0.04, 2.58) |
|||||||
| Week 12 (Follow–up) |
20.10 (10.31) |
13.25 (8.85) |
6.86 (4.59, 9.12) |
10.83 (5.35) | 7.36 (5.31) |
3.48 (2.22, 4.74) |
11.14 (9.39) | 9.22 (9.29) |
1.92 (–0.28, 4.12) |
6.83 (5.46) |
5.52 (6.50) |
1.31 (–0.10, 2.73) |
|||||||
| Week 20 (Follow–up) |
19.56 (10.64) |
13.68 (9.48) |
5.88 (3.50, 8.25) |
10.83 (5.26) |
7.37 (5.43) |
3.46 (2.20, 4.72) |
10.86 (9.75) | 9.59 (9.12) |
1.27 (–0.96, 3.49) |
6.86 (5.64) |
5.76 (6.76) |
1.09 (–0.37, 2.56) |
|||||||
Notes: all the outcome measurements were assessed as the score changes from baseline. Data were shown by mean and standard deviation (SD). MD (95%CI): Mean difference between groups A and B, and 95% CI with standard error computing from the standard deviation of groups A and B. If 95% CI contains 0, there was not statistically significant between groups A and B. For group A, it demonstrated superiority in FSS from 4 weeks to 20 weeks, and in SPHERE from 2 weeks to 20 weeks. There was no statistical difference between A and B groups in SDS and HAMA during the trial. FSS: Fatigue Severity Scale; SPHERE: Somatic and Psychological Health Report; SDS: Self-rating Depression Scale; HAMA: Hamilton anxiety scale.
All the symptom scores improved from baseline in both groups. The continual improvement was seen as treatment continued, and sustained during the following 12 weeks after the end of treatment (Figure 3).
Between groups, significant differences were observed in SPHERE, in which significantly higher score changes were seen in group A after 2 weeks treatment and sustained until the end of follow-up period (Table 2). But for SDS and HAMA, the improvement in symptom scores did not differ significantly between the groups.
3.3. Safety assessments
Totally 12 adverse events (8 in group A, 4 in group B) were reported, in which mild skin burns (5/6) and mild oral ulcer (1/6) were or may be related with moxibustion; mild faint during needling (1/6) and pain or hematoma at the puncture point (5/6) were related with acupuncture. No severe adverse events were reported.
4. DISCUSSION
Due to the nonorganic pathophysiology, CFS is associated with suboptimal health status and the present treatment of CFS is given based on limited evidence from clinical studies.15-17 CFS is named fatigue syndrome in TCM theory and Yang Qi deficiency is considered as the main reason. Moxa therapy is used for Yang Qi deficiency syndrome for thousands of years in China. As one of the special traditional Chinese moxibustion methods, the ginger-indirect moxibustion on the back (Governor Vessel and Bladder Meridian) is characterized as strong yang-warming effect through enlarging moxa therapy area from single points to the Yang Vessels and extending moxa therapy time from half an hour to 45 min. Although the ginger-indirect moxibustion on the back is considered to be one of the optimal treatments for fatigue symptoms relief and has been applied in clinics, its effect lacks evidence from high quality randomized controlled trials. Therefore, we designed the randomized controlled trial to evaluate the effect and safety of the ginger-indirect moxibustion on Governor Vessel and 1st line of Bladder Meridian on the back in the treatment of CFS, for the purpose of providing a valid treatment approach for CFS. The results indicated that ginger-indirect moxibustion is a safe and effective intervention to relieve fatigue and accompanying physical symptoms.
So far, acupuncture is thought to be effective in relief of CFS symptoms, which fits in with the result of our study.3,11,18 In our trial, an improvement of 9.12 on the FSS score after 4-week acupuncture treatment was observed, and the improvement achieved 14.03 at the end of 8-week acupuncture treatment and maintained the similar level at the 12th week, indicating a long-term effect of acupuncture. The similar improvement was also found in SPHERE. Also, acupuncture therapy is enc-ouraged in the treatment for anxiety and depression.19,20 Although patients in our trial didn't reach the diagnosis of anxiety and depression, the improvement of SDS and HAMA scores was detected in group A (acupuncture group).
In this trial, we found significant differences in FSS and SPHERE score change between groups of acupuncture alone and the combination of ginger-indirect moxibustion with acupuncture at most of all visit times, suggesting the positive effect of ginger-indirect moxi-bustion in CFS. With the ginger-indirect moxibustion treatment prolonged, the change of FSS and SPHERE scores increased gradually (from 7.47 to 20.22 in FSS; from 3.70 to 10.67 in SPHERE), and the effect persisted during 12-week follow-up.21,22 The observation that indirect moxibustion was effective in relieving CFS symptoms has also been reported in other RCTs.21,22 The therapeutic effect of moxibustion may be explained by its advantage in vagus nerve activation and antioxidant activity modification.
The minimum clinically important difference (MCID) is used to interpret the clinical relevance of results. However, there is a lack of consensus about the size of MCID in fatigue.23 The lasted evidence from the study of MCID for seven measures of fatigue in Swedish patients with systemic lupus erythematosus indicated the score change of 15.2 in FSS may be the clinically meaningful difference. In our study, patients were included as CFS, and to all of them, fatigue measured by FSS has been continually improved after treatment. In FSS, the improve rates were from18.82% to 50.94% in group A and 15.36% to 35.56% in group B, which was clinically different.
However, the differences in anxiety and depression improvement between groups were not statistically significant, demonstrating that acupuncture may play more important role in mental distress relief than moxa therapy. The efficacy of moxibustion in anxiety or depression was lack of evidence supporting, because research of its effect in mental disease is rare, so more studies are required to clarify the result and explore the underlying mechanism. On the other hand, in this trial, patients in group A didn't meet the diagnostic criteria of depression (SDS ≥ 50) and in group B just met minimum diagnostic criteria; patients in both groups didn't meet the diagnostic criteria of anxiety (HAMA ≥ 14), which may explain part of the result.
For the large sample, our research was one of the few studies to provide evidence for ginger-indirect moxibustion in treating CFS. The strengths of our study included a central randomization by independent company to confirm adequate allocation concealment and comparability between groups, and a strict quality control system by designated person to assure the standardization of the procedure and reliable results.
There are limitations of our study as well: (a) due to the purpose of our trial and in consideration of patient compliance, a group of ginger-indirect moxibustion alone was not designed; (b) a waiting-list control group was not designed, which may not exclude self-healing from the therapeutic effect; (c) anxiety was assessed by HAMA, but not by self-rating anxiety scale, which was a similar self-rating scale as SDS in measuring depression; (d) objective indicators, such as immunity indexes were not assessed, which will be studied in the further research to enrich results.
In conclusion, the ginger-indirect moxibustion on Governor Vessel and 1st line of Bladder Meridian on the back is safe and effective in relieving fatigue and accompanying physical symptoms, and the effects could last at least 12 weeks after an 8-week treatment. But its effect for psychological improvement in CFS was not clearly detected, which needs more research to verify.
5. ACKNOWLEDGMENTS
We would like to thank Chengdu BM Clinical Researches Ltd., for their cooperation and support in the central randomization scheme, e-case report form management and clinical quality monitoring. Our gratitude is also extended to clinical staffs evolving in the trial performance and effect assessment in all participant Hospitals.
REFERENCES
- 1. Reeves WC, Lloyd A, Vernon SD, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res 2003; 3: 25-33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Capelli E, Zola R, Lorusso L, Venturini L, Sardi F, Ricevuti G. Chronic fatigue syndrome/myalgic encephalomyelitis: an update. Int J Immunopathol Pharmacol 2010; 23: 981-9. [DOI] [PubMed] [Google Scholar]
- 3. Ng SM, Yiu YM. Acupuncture for chronic fatigue syndrome: a randomized, sham-controlled trial with single-blinded design. Altern Ther Health Med 2013; 19: 21-6. [PubMed] [Google Scholar]
- 4. Oka T, Tanahashi T, Chijiwa T, Lkhagvasuren B, Sudo N, Oka K. Isometric yoga improves the fatigue and pain of patients with chronic fatigue syndrome who are resistant to conventional therapy: a randomized, controlled trial. Bio Psycho Soc Med 2014; 8: 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Price JR, Mitchell E, Tidy E, et al. Cognitive behaviour therapy for chronic fatigue syndrome in adults (review). Cochrane Database Syst Rev 2008; 2008: 1-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. White PD, Goldsmith KA, Johnson AL, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011; 377: 823-36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Van Cauwenbergh D, De Kooning M, Ickmans K, Nijs J. How to exercise people with chronic fatigue syndrome: evidence-based practice guidelines. Eur J Clin Invest 2012; 42: 1136-44. [DOI] [PubMed] [Google Scholar]
- 8. Wang T, Zhang Q, Xue X, Yeung A. A systematic review of acupuncture and moxibustion treatment for chronic fatigue syndrome in China. Am J Chin Med 2008; 36: 1-24. [DOI] [PubMed] [Google Scholar]
- 9. Wang YY, Li XX, Liu JP, Luo H, Ma LX, Alraek T. Traditional Chinese Medicine for chronic fatigue syndrome: a systematic review of randomized clinical trials. Complement Ther Med 2014; 22: 826-33. [DOI] [PubMed] [Google Scholar]
- 10. Tan HJ, Luo TT, Qu WZ, Wen MX, Yang L, Wu X. Acupoint selection rules of acupuncture for chronic fatigue syndrome based on data mining technology. Zhong Guo Zhong Yi Ji Chu Yi Xue Za Zhi 2017; 23: 242-4+98. [Google Scholar]
- 11. Wang T, Xu C, Pan K, Xiong H. Acupuncture and moxibustion for chronic fatigue syndrome in Traditional Chinese Medicine: a systematic review and Meta-analysis. BMC Complement Altern Med 2017; 17: 163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Lerdal A, Wahl A, Rustoen T, Hanestad BR, Moum T. Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health 2005; 33: 123-30. [DOI] [PubMed] [Google Scholar]
- 13. Hickie IB, Davenport TA, Hadzi-Pavlovic D, et al. Development of a simple screening tool for common mental disorders in general practice. Med J Aust 2001; 175(Suppl):S10-7. [DOI] [PubMed] [Google Scholar]
- 14. Zhang RF. A randomized controlled study on treating chronic fatigue syndrome by acupuncturing acupoints on meridians. Chengdu: Chengdu University of Traditional Chinese Medicine, 2012: 21-41. [Google Scholar]
- 15. Wang W, Russell A, Yan Y. Traditional Chinese Medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health. EPMA J 2014; 5: 4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. National Collaborating Centre for Primary Care (UK), Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy) in adults and children (Royal College of General Practitioners, London, 2007) . [PubMed] [Google Scholar]
- 17. Yancey JR, Thomas SM. Chronic fatigue syndrome: diagnosis and treatment. Am Fam Physician 2012; 86: 741-6. [PubMed] [Google Scholar]
- 18. Kim JE, Seo BK, Choi JB, et al. Acupuncture for chronic fatigue syndrome and idiopathic chronic fatigue: a multicenter, nonblinded, randomized controlled trial. Trials 2015; 16: 314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Amorim D, Amado J, Brito I, et al. Acupuncture and electroacupuncture for anxiety disorders: a systematic review of the clinical research. Complement Ther Clinl Pract 2018; 31: 31-7. [DOI] [PubMed] [Google Scholar]
- 20. Bosch P, van den Noort M, Staudte H, Lim S. Schizophrenia and depression: a systematic review of the effectiveness and the working mechanisms behind acupuncture. Explore (NY) 2015; 11: 281-91. [DOI] [PubMed] [Google Scholar]
- 21. Kim HG, Yoo SR, Park HJ, Son CG. Indirect moxibustion (CV4 and CV8) ameliorates chronic fatigue: a randomized, double-blind, controlled study. J Altern Complement Med 2013; 19: 134-40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Shu Q, Wang H, Litscher D, et al. Acupuncture and moxibustion have different effects on fatigue by regulating the autonomic nervous system: a pilot controlled clinical trial. Sci Rep 2016; 6: 37846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. S Pettersson, IE Lundberg, MH Liang, et al. Determination of the minimal clinically important difference for seven measures of fatigue in Swedish patients with systemic lupus erythematosus. Scand J Rheumatol 2015; 44: 1-5. [DOI] [PubMed] [Google Scholar]